Experts question early release of incomplete trial data.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
The RTS,S Clinical Trials Partnership New Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1102287 (2011).
Farlow, A. In The Science, Economics, and Politics of Malaria Vaccine Policy (2006). Chapter available at http://go.nature.com/8oxle3
White, N. J. New Engl. J. Med. http://dx.doi.org/10.1056/NEJMe1111777 (2011).
Moorthy, V. S., Reed, Z. & Smith, P. G. Vaccine 27, 624-628 (2009).
World Health Organization et al. (2006). Available at http://go.nature.com/i1jdf7
Related links in Nature Research
GAVI Alliance vastly exceeds US$3.7bn fundraising target
Pharma pledges to slash vaccine prices for developing world
Related external links
Malaria Vaccine Technology Roadmap
Bill & Melinda Gates Foundation on malaria
Rights and permissions
About this article
Cite this article
Butler, D. Malaria vaccine results face scrutiny. Nature 478, 439–440 (2011). https://doi.org/10.1038/478439a